Category: Analysis - Page 6 - Psychedelic Alpha

Read more about the article Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Post published:July 16, 2024
Post category:Analysis News Pα+

Read more about the article Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Post published:July 9, 2024
Post category:Analysis News Pα+

Read more about the article In Brief: ICER Issues Final Evidence Report and Recommendations Re: MDMA-Assisted Therapy; Lykos Responds

In Brief: ICER Issues Final Evidence Report and Recommendations Re: MDMA-Assisted Therapy; Lykos Responds

Post published:June 27, 2024
Post category:Analysis News

Read more about the article No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine for TRD

No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine for TRD

Post published:June 21, 2024
Post category:Analysis News Pα+

Read more about the article Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals

Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals

Post published:June 13, 2024
Post category:Analysis News

Read more about the article Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming “No” Vote

Analysis: FDA Advisory Committee Snubs MDMA-Assisted Therapy for PTSD in Overwhelming “No” Vote

Post published:June 11, 2024
Post category:Analysis News Pα+

Read more about the article Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD

Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD

Post published:June 4, 2024
Post category:Analysis News

Read more about the article ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

Post published:May 31, 2024
Post category:Analysis News Pα+

Read more about the article Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

Post published:May 29, 2024
Post category:Analysis Pα+

Read more about the article What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

Post published:May 27, 2024
Post category:Analysis Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.